CoChat

The effects of cholesterol on learning and memory

Open access
Schreurs, Bernard G. · 2010 · Neuroscience & Biobehavioral Reviews
Cited by 105

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

Cholesterol is vital to normal brain function including learning and memory but that involvement is as complex as the synthesis, metabolism and excretion of cholesterol itself. Dietary cholesterol influences learning tasks from water maze to fear conditioning even though cholesterol does not cross the blood brain barrier. Excess cholesterol has many consequences including peripheral pathology that can signal brain via cholesterol metabolites, proinflammatory mediators and antioxidant processes. Manipulations of cholesterol within the central nervous system through genetic, pharmacological, or metabolic means circumvent the blood brain barrier and affect learning and memory but often in animals already otherwise compromised. The human literature is no less complex. Cholesterol reduction using statins improves memory in some cases but not others. There is also controversy over statin use to alleviate memory problems in Alzheimer’s disease. Correlations of cholesterol and cognitive function are mixed and association studies find some genetic polymorphisms are related to cognitive function but others are not. In sum, the field is in flux with a number of seemingly contradictory results and many complexities. Nevertheless, understanding cholesterol effects on learning and memory is too important to ignore.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neubiorev.2010.04.010

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 47 references

Research works printed but not linked: 187

  1. Arndt, 2001, Methods for behavioural phenotyping of mouse mutants. How to keep the overview, Behav. Brain Res., 125, 39, 10.1016/S0166-4328(01)00285-6 · doi:10.1016/s0166-4328(01)00285-6
  2. Arvanitakis, 2008, Statins, incident Alzheimer disease, change in cognitive function, and neuropathology, Neurology, 70, 1795, 10.1212/01.wnl.0000288181.00826.63 · DOI · Paper page
  3. Atzmon, 2002, Plasma HDL levels highly correlate with cognitive function in exceptional longevity, J. Gerontol. Ser. A Biol. Sci. Med. Sci., 57A, M712, 10.1093/gerona/57.11.M712 · DOI · Paper page
  4. Bahia, 2008, Polymorphisms of APOE and LRP genes in Brazilian individuals with Alzheimer disease, Alzheimer's Dis. Assoc. Disord., 22, 61, 10.1097/WAD.0b013e31815a9da7 · DOI
  5. Baldwin, 2009, Neuropsychological assessment in the diagnosis of Alzheimer's disease, Curr. Protocols Neurosci., 49, 1031, 10.1002/0471142301.ns1003s49 · DOI
  6. Bales, K.R. Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease. Neuropharmacology, in press.
  7. Baranowski, 2008, Biological role of liver X receptors, J. Physiol. Pharmacol., 59, 31
  8. Beach, 2008, Physiologic origins of age-related β-amyloid deposition, Neurodegenerative Dis., 5, 143, 10.1159/000113685 · DOI
  9. Bernick, 2005, Statins and cognitive function in the elderly, Neurology, 65, 1388, 10.1212/01.wnl.0000182897.18229.ec · DOI · Paper page
  10. Bertram, 2007, The LDLR locus in Alzheimer's disease: a family-based study and meta-analysis of case-control data, Neurobiol. Aging, 18, e18
  11. Billings, 2007, Learning decreases Aβ*56 and tau pathology and ameliorates behavioral decline in 3xTg-AD mice, J. Neurosci., 27, 751, 10.1523/JNEUROSCI.4800-06.2007 · DOI · Paper page
  12. Bjorkhem, 2002, Do oxysterols control cholesterol homeostasis?, J. Clin. Invest., 110, 725, 10.1172/JCI0216388 · doi:10.1172/jci0216388 · Paper page
  13. Bjorkhem, 2009, Are side-chain oxidized oxysterols regulators also in vivo?, J. Lipid Res., 50, S213, 10.1194/jlr.R800025-JLR200 · DOI · Paper page
  14. Bjorkhem, 2009, Oxysterols and neurodegenerative disorders, Mol. Aspects Med., 30, 171, 10.1016/j.mam.2009.02.001 · DOI · Paper page
  15. Bour, 2008, Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks, Behav. Brain Res., 193, 174, 10.1016/j.bbr.2008.05.008 · DOI · Paper page
  16. Brooks, 2004, Behavioural profiles of inbred mouse strains used as transgenic backgrounds. I: motor tests, Genes Brain Behav., 3, 206, 10.1111/j.1601-183X.2004.00072.x · DOI · Paper page
  17. Brouwers, 2008, Molecular genetics of Alzheimer's disease: an update, Ann. Med., 18, 1
  18. Burgess, 2008, ABCG1 influences the brain cholesterol biosynthetic pathway but does not affect amyloid precursor protein or apolipoprotein E metabolism in vivo, J. Lipid Res., 49, 1254, 10.1194/jlr.M700481-JLR200 · DOI · Paper page
  19. Canevari, 2007, Alzheimer's disease and cholesterol: the fat connection, Neurochem. Res., 32, 739, 10.1007/s11064-006-9200-1 · DOI
  20. Carlsson, 2008, Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer's disease, J. Alzheimer's Dis., 13, 187, 10.3233/JAD-2008-13209 · DOI · Paper page
  21. Carlsson, 2009, increased atherogenic lipoproteins are associated with cognitive impairment: effects of statins and subclinical atherosclerosis, Alzheimer's Dis. Assoc. Disord., 23, 11, 10.1097/WAD.0b013e3181850188 · DOI · Paper page
  22. Chafekar, 2008, Oligomer-specific aβ toxicity in cell models is mediated by selective uptake, Biochim. Biophys. Acta, 1782, 523, 10.1016/j.bbadis.2008.06.003 · DOI
  23. Chen, 2002, Learning and recall in subjects at genetic risk for Alzheimer's disease, J. Neuropsych. Clin. Neurosci., 14, 58, 10.1176/jnp.14.1.58 · DOI
  24. Chen, 2008, Caffeine blocks disruption of the blood brain barrier in a rabbit model of Alzheimer's disease, J. Neuroinflamm., 5, 1, 10.1186/1742-2094-5-12 · DOI · Paper page
  25. Darwish, 2010, Dietary cholesterol impairs memory and memory increases brain cholesterol and sulfatide levels, Behav. Neurosci., 124, 115, 10.1037/a0018253 · DOI
  26. de Frias, 2007, Cholesterol and triglycerides moderate the effect of apolipoprotein E on memory functioning in older adults, J. Gerentol. Psychol. Sci., 62B, P112, 10.1093/geronb/62.2.P112 · DOI · Paper page
  27. Deane, 2009, Clearance of amyloid-β across the blood-brain barrier: implications for therapies in Alzheimer's disease, CNS Neurol. Disord. Drug Targets, 8, 16, 10.2174/187152709787601867 · DOI · Paper page
  28. Deary, 2002, Cognitive change and the APOE ɛ4 allele, Nature, 418, 932, 10.1038/418932a · DOI · Paper page
  29. Despande, 2006, Different conformations of amyloid β induce toxicity by distinct mechanisms in human cortical neurons, J. Neurosci., 26, 6011, 10.1523/JNEUROSCI.1189-06.2006 · DOI · Paper page
  30. Deyo, 1989, Nimodipine facilitates associative learning in aging rabbits, Science, 243, 809, 10.1126/science.2916127 · DOI · Paper page
  31. Di Filippo, 2008, Neuroinflammation and synaptic plasticity: theoretical basis for a movel, immune-centred, therapeutic approach to neurological disorders, Trends Pharmacol. Sci., 29, 402, 10.1016/j.tips.2008.06.005 · DOI · Paper page
  32. Dik, 2001, Memory complaints and APOE-ɛ4 accelerate cognitive decline in cognitively normal elderly, Neurology, 57, 2217, 10.1212/WNL.57.12.2217 · DOI · Paper page
  33. Dufour, 2006, Cholesterol-enriched diet affects spatial learning and synaptic function in hippocampal synapses, Brain Res., 1103, 88, 10.1016/j.brainres.2006.05.086 · DOI
  34. Eddins, 2009, Hippocampal infusion of apolipoprotein E peptides induce long-lasting cognitive impairment, Brain Res. Bull., 79, 111, 10.1016/j.brainresbull.2009.01.003 · DOI
  35. Elder, 2007, Elevated plasma cholesterol does not affect brain Aβ in mice lacking the low-density lipoprotein receptor, J. Neurochem., 102, 1220, 10.1111/j.1471-4159.2007.04614.x · DOI · Paper page
  36. Elias, 2005, Serum cholesterol and cognitive performance in the Framingham heart study, Psychosom. Med., 67, 24, 10.1097/01.psy.0000151745.67285.c2 · DOI · Paper page
  37. Endo, 1996, Impairment of maze learning in rats following long-term glucocorticoid treatments, Neurosci. Lett., 203, 199, 10.1016/0304-3940(95)12296-6 · DOI
  38. Esler, 2002, Apolipoprotein E affects amyloid formation but not amyloid growth in vitro: mechanistic implications for ApoE4 enhanced amyloid burden and risk for Alzheimer's disease, Amyloid: J. Protein Folding Disord., 9, 1, 10.3109/13506120209072439 · DOI
  39. Evans, 2009, Statin-associated adverse cognitive effects: survey results from 171 patients, Pharmacotherapy, 29, 800, 10.1592/phco.29.7.800 · DOI · Paper page
  40. Evans, 2000, Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans, Neurology, 54, 240, 10.1212/WNL.54.1.240 · DOI · Paper page
  41. Fassbender, 2002, Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide, Neurology, 59, 1257, 10.1212/WNL.59.8.1257 · DOI · Paper page
  42. Fernandez del Pozo, 2006, Polymorphism in the cholesterol 24S-hydroxylase gene (CYP46A1) associated with the APOEpsilon3 allele increases the risk of Alzheimer's disease and of mild cognitive impairment progressing to Alzheimer's disease, Dement. Geriatr. Cogn. Disord., 21, 81, 10.1159/000090215 · DOI
  43. Flory, 2000, Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults, Am. J. Med. Genet. (Neuropsych. Genet.), 96, 707, 10.1002/1096-8628(20001204)96:6<707::AID-AJMG1>3.0.CO;2-V · DOI · Paper page
  44. Foster, 2006, Biological markers of age-related memory deficits. Treatment of senescent physiology, CNS Drugs, 20, 153, 10.2165/00023210-200620020-00006 · DOI
  45. Frears, 1999, The role of cholesterol in the biosynthesis of β-amyloid, NeuroReport, 10, 1699, 10.1097/00001756-199906030-00014 · DOI · Paper page
  46. Fu, 2009, Cholesterol 24-hydroxylase (CYP46A1) polymorphisms are associated with faster cognitive deterioration in Chinese older persons: a two-year follow up study, Int. J. Geriatr. Psychiatry, 24, 921, 10.1002/gps.2196 · DOI
  47. Ghribi, 2006, Deposition of iron and β-amyloid plaques is associated with cortical cellular damage in rabbits fed with long-term cholesterol-enriched diets, J. Neurochem., 99, 438, 10.1111/j.1471-4159.2006.04079.x · DOI · Paper page
  48. Ghribi, 2006, High cholesterol content in neurons increases BACE, β-amyloid, and phosphorylated tau levels in rabbit hippocampus, Exp. Neurol., 200, 460, 10.1016/j.expneurol.2006.03.019 · DOI · Paper page
  49. Gotto, 2001, Pleiotropic effects of statins: do they matter?, Curr. Opin. Lipidol., 12, 391, 10.1097/00041433-200108000-00004 · DOI · Paper page
  50. Granholm, 2008, Effects of a saturated fat and high cholesterol diet on memory and hippocampal morphology in middle-aged rats, J. Alzheimer's Dis., 14, 133, 10.3233/JAD-2008-14202 · DOI · Paper page
  51. Grimm, 2007, Amyloid beta as a regulator of lipid homeostasis, Trends Mol. Med., 13, 337, 10.1016/j.molmed.2007.06.004 · DOI
  52. Hansson, 2008, Inflammation and atherosclerosis, Ann. Rev. Pathol. Mech. Dis., 1, 297, 10.1146/annurev.pathol.1.110304.100100 · DOI · Paper page
  53. Harris-White, 2004, Role of LRP in TGFbeta2-mediated neuronal uptake of Abeta and effects on memory, J. Neurosci. Res., 77, 217, 10.1002/jnr.20149 · DOI · Paper page
  54. Hartmann, 1994, Apolipoprotein E and cholesterol affect neuronal calcium signalling: the possible relationship to β-neurotoxicity, Biochem. Biophys. Res. Commun., 200, 1185, 10.1006/bbrc.1994.1576 · DOI
  55. Hartmann, 2001, Cholesterol, Aβ and Alzheimer's disease, Trends Neurosci., 11, S45, 10.1016/S0166-2236(00)01990-1 · DOI
  56. Hartmann, 2006, Role of amyloid precursor protein, amyloid-β and γ-secretase in cholesterol maintenance, Neurodegenerative Dis., 3, 305, 10.1159/000095271 · DOI
  57. Heverin, 2005, Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain, J. Lipid Res., 46, 1047, 10.1194/jlr.M500024-JLR200 · DOI · Paper page
  58. Hoglund, 2005, The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease, Dement. Geriatr. Cogn. Disord., 19, 256, 10.1159/000084550 · DOI · Paper page
  59. Hoshino, 2002, Gene dose effect of the APOE-ɛ4 allele on plasma HDL cholesterol level in patients with Alzheimer's disease, Neurobiol. Aging, 23, 41, 10.1016/S0197-4580(01)00252-4 · DOI
  60. Hoyer, 2007, Alzheimer disease - no traget for statin treatment. A mini review, Neurochem. Res., 32, 695, 10.1007/s11064-006-9168-x · DOI
  61. Hudry, 2009, Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after onset of amyloid plaques in mouse models of Alzheimer's disease, Mol. Therapy, 18, 44, 10.1038/mt.2009.175 · DOI · Paper page
  62. Jacova, 2007, Neuropsychological testing and assessment of dementia, Alzheimer's Dementia, 3, 299, 10.1016/j.jalz.2007.07.011 · DOI · Paper page
  63. Jaeger, 2010, Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition, J. Alzheimer's Dis., 17, 553, 10.3233/JAD-2009-1074 · DOI · Paper page
  64. Jarvik, 1995, Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease, Neurology, 45, 1092, 10.1212/WNL.45.6.1092 · DOI · Paper page
  65. Jasinska, 2007, Statins: a new insight into their mechanisms of action and consequent pleiotropic effects, Pharmacol. Rep., 59, 483
  66. Jaya Prasanthi, 2008, Regulation of β-amyloid levels in the brain of cholesterol-fed rabbit, a model system for sporadic Alzheimer's disease, Mech. Ageing Dev., 29, 649, 10.1016/j.mad.2008.09.002 · DOI · Paper page
  67. Jessup, 2004, Lipid peroxidation in atherogenesis: an overview, Biochem. Soc. Trans., 32, 134, 10.1042/bst0320134 · DOI
  68. Jick, 2000, Statins and the risk of dementia, Lancet, 356, 1627, 10.1016/S0140-6736(00)03155-X · DOI · Paper page
  69. Joseph, 2001, Copernicus revisited: amyloid beta in Alzheimer's disease, Neurobiol. Aging, 22, 131, 10.1016/S0197-4580(00)00211-6 · DOI · Paper page
  70. Juva, 2000, Apolipoprotein E, cognitive function, and dementia in a general population aged 85 years and over, Int. Psychogeriatr., 12, 379, 10.1017/S1041610200006487 · DOI
  71. Kainuma, 2006, Cholesterol-fed rabbit as a unique model of nonalcoholic, nonobese, non-insulin-resistant fatty liver disease with characteristic fibrosis, J. Gastroenterol., 41, 971, 10.1007/s00535-006-1883-1 · DOI
  72. Kane, 1999, Effect of chronic nimodipine on spatial learning and on long-term potentiation, Behav. Brain Res., 98, 95, 10.1016/S0166-4328(98)00057-6 · DOI
  73. Kessler, 1986, In vivo modulation of brain cholesterol level and learning performance by a novel plant lipid: indication of interactions between hippocampal-cortical cholesterol and learning, Life Sci., 38, 1185, 10.1016/0024-3205(86)90173-6 · DOI
  74. Kim, 2002, Apolipoprotein E ɛ4 Allele is not associated with the cognitive impairment in community-dwelling normal elderly individuals, Int. J. Geriatr. Psychiatry, 17, 635, 10.1002/gps.664 · DOI
  75. Kim, 2008, Role of ATP-binding cassette transporters in brain lipid transport and neurological disease, J. Neurochem., 104, 1145, 10.1111/j.1471-4159.2007.05099.x · DOI · Paper page
  76. Kirsch, 2003, Brain cholesterol, statins and Alzheimer's disease, Pharmacopsychiatry, 36, S113, 10.1055/s-2003-43058 · DOI · Paper page
  77. Koladiya, 2008, Ameliorative role of atorvastatin and pitavastatin in L-methionine induced vascular dementia in rats, BMC Pharmacol., 9, 8
  78. Kolsch, 2004, Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients, Neurosci. Lett., 368, 303, 10.1016/j.neulet.2004.07.031 · DOI
  79. Kotti, 2006, Brain cholesterol turnover required for geranylgeraniol production and learning in mice, Proc. Natl. Acad. Sci. U.S.A., 103, 3869, 10.1073/pnas.0600316103 · DOI · Paper page
  80. Koudinov, 2001, Essential role of cholesterol in synaptic plasticity and neuronal degeneration, FASEB J., 15, 1858, 10.1096/fj.00-0815fje · DOI · Paper page
  81. Ledesma, 2006, Amyloid excess in Alzheimer's disease: what is cholesterol to be blamed for?, FEBS Lett., 580, 5525, 10.1016/j.febslet.2006.06.038 · DOI · Paper page
  82. Lefterov, I., Fitz, N.F., Cronican, A., Lefterov, P., Staufenbiel, M., Koldamova, R., 2009. Memory deficits in APP23/Abca1+/- mice correlate with the level of Abeta oligomers. ASN Neuro 1. · DOI · Paper page
  83. Lesser, 2009, Serum lipid levels are related to Alzheimer's pathology in nursing home residents, Dement. Geriatr. Cogn. Disord., 27, 42, 10.1159/000189268 · DOI
  84. Li, 2003, Association of aortic atherosclerosis with cerebral β-amyloidosis and learning deficits in a mouse model of Alzheimer's disease, Am. J. Pathol., 163, 2155, 10.1016/S0002-9440(10)63572-9 · DOI · Paper page
  85. Li, 2006, Simvastatin enhances learning and memory independent of amyloid load in mice, Ann. Neurol., 60, 729, 10.1002/ana.21053 · DOI · Paper page
  86. Liu, 1998, Amyloid β peptide alters intracellular vesicle trafficking and cholesterol homeostasis, Proc. Natl. Acad. Sci. U.S.A., 95, 13266, 10.1073/pnas.95.22.13266 · DOI · Paper page
  87. Lominska, 2001, Apolipoprotein E deficiency effects on learning in mice are dependent upon the background strain, Behav. Brain Res., 120, 23, 10.1016/S0166-4328(00)00365-X · DOI
  88. Lu, 2007, Statins increase neurogenesis in the dentate gyrus, reduce delayed neuronal death in the hippocampal CA3 region, and improve spatial learning in rat after traumatic brain injury, J. Neurotrauma, 24, 1132, 10.1089/neu.2007.0288 · DOI · Paper page
  89. Lu, 2009, Trace amounts of copper exacerbate beta amyloid-induced neurotoxicity in the cholesterol-fed mice through TNF-mediated inflammatory pathway, Brain Behav. Immun., 23, 193, 10.1016/j.bbi.2008.09.003 · DOI
  90. Ma, 2007, Involvment of β-site APP cleaving emzyme 1 (BACE1) in amyloid precusor protein-mediated enhancement of memory and activity-dependent synaptic plasticity, Proc. Natl. Acad. Sci., 104, 8167, 10.1073/pnas.0609521104 · DOI · Paper page
  91. Mahfouz, 2000, Cholesterol-rich diets have different effects on lipid peroxidation, cholesterol oxides, and antioxidant enzymes in rats and rabbits, J. Nutr. Biochem., 11, 293, 10.1016/S0955-2863(00)00083-8 · DOI
  92. Martins, 2009, Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease, J. Neurochem., 111, 1275, 10.1111/j.1471-4159.2009.06408.x · DOI · Paper page
  93. Masse, 2005, Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease, J. Neurol. Neurosurg. Psych., 76, 1624, 10.1136/jnnp.2005.063388 · DOI · Paper page
  94. Mayeux, 2001, Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E, Neurobiol. Aging, 22, 683, 10.1016/S0197-4580(01)00223-8 · DOI
  95. McLaurin, 2003, Cholesterol, a modulator of membrane-associated aβ-fibrillogenesis, Pharmacopsychiatry, 36, S130, 10.1055/s-2003-43054 · DOI
  96. Micale, 2008, Behavioral effects of dietary cholesterol in rats tested in experimental models of mild stress and cognition tasks, Eur. Neuropsychopharmacol., 18, 462, 10.1016/j.euroneuro.2007.11.006 · DOI
  97. Miller, 1994, Cholesterol treatment facilitates spatial learning performance in DBA/2Ibg mice, Pharmacol. Biochem. Behav., 49, 257, 10.1016/0091-3057(94)90487-1 · DOI
  98. Morgan, 2003, Learning and memory deficits in APP transgenic mouse models of amyloid deposition, Neurochem. Res., 28, 1029, 10.1023/A:1023255106106 · DOI
  99. Muldoon, 2000, Effects of lovastatin on cognitive function and psychological well-being, Am. J. Med., 108, 538, 10.1016/S0002-9343(00)00353-3 · DOI · Paper page
  100. Muldoon, 1997, Serum cholesterol and intellectual performance, Psychosom. Med., 59, 382, 10.1097/00006842-199707000-00008 · DOI · Paper page
  101. Nayler, 1999, Review of preclinical data of calcium channel blockers and atherosclerosis, J. Cardiovasc. Pharmacol., 33, 10.1097/00005344-199900002-00003 · DOI
  102. Notkola, 1998, Serum total cholesterol, apolipoprotein Eɛ4 allele, and Alzheimer's disease, Neuroepidemiology, 17, 14, 10.1159/000026149 · DOI · Paper page
  103. O’Brien, 2002, Developmental sensitivity of associative learning to cholesterol synthesis inhibitors, Behav. Brain Res., 129, 141, 10.1016/S0166-4328(01)00342-4 · DOI
  104. Obrenovich, 2002, Amyloid-β: a (life) preserver for the brain, Neurobiol. Aging, 23, 1097, 10.1016/S0197-4580(02)00038-6 · DOI
  105. Panza, 2006, Lipid metabolism in cognitive decline and dementia, Brain Res. Rev., 51, 275, 10.1016/j.brainresrev.2005.11.007 · DOI · Paper page
  106. Papassotiropoulos, 2002, 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia, J. Psychiatr. Res., 36, 27, 10.1016/S0022-3956(01)00050-4 · DOI · Paper page
  107. Papassotiropoulos, 2005, A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease, J. Clin. Psychiatry, 66, 940, 10.4088/JCP.v66n0720 · DOI · Paper page
  108. Parale, 2006, Effects of atorvastatin on higher functions, Eur. J. Clin. Pharmacol., 62, 259, 10.1007/s00228-005-0073-z · DOI
  109. Parkinson, P.F., Kannangara, T.S., Eadie, B.D., Burgess, B.L., Wellington, C.L., Christie, B.R., 2009. Cognition, learning behaviour and hippocampal synaptic plasticity are not disrupted in mice over-expressing the cholesterol transporter ABCG1. Lipids in Health and Disease 8. · DOI
  110. Perry, 2009, No association between cognitive acheivements, academic performance and serum cholesterol concentrations among school-aged children, Nutr. Neurosci., 12, 160, 10.1179/147683009X423328 · DOI
  111. Pickering, 2007, Pro-inflammatory cytokines and their effects in the dentate gyrus, Prog. Brain Res., 163, 339, 10.1016/S0079-6123(07)63020-9 · DOI · Paper page
  112. Poirier, 2005, Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease, Neurobiol. Aging, 26, 355, 10.1016/j.neurobiolaging.2004.09.003 · DOI · Paper page
  113. Qiu, 2006, A fresh look at an ancient family: emerging roles for low density lipoprotein receptors in synaptic plasticity and memory formation, Neurobiol. Learn. Mem., 85, 16, 10.1016/j.nlm.2005.08.009 · DOI
  114. Quartermain, 2000, Chronic administration of the Ca2+ channel blocker amlodipine facilitates learning and memory in mice, Eur. J. Pharmacol., 399, 57, 10.1016/S0014-2999(00)00368-X · DOI
  115. Quartermain, 2001, Calcium channel antagonists enhance retention of passive avoidance and maze learning in mice, Neurobiol. Learn. Mem., 75, 77, 10.1006/nlme.1999.3958 · DOI
  116. Raffai, 2003, Cholesterol: from heart attacks to Alzheimer's disease, J. Lipid Res., 44, 1423, 10.1194/jlr.R300007-JLR200 · DOI · Paper page
  117. Rafnsson, 2009, Peripheral arterial disease and cognitive function, Vasc. Med., 14, 51, 10.1177/1358863X08095027 · DOI
  118. Reid, 2007, Alzheimer's disease: cholesterol, membrane rafts, isoprenoids and statins, J. Cell. Mol. Med., 11, 383, 10.1111/j.1582-4934.2007.00054.x · DOI · Paper page
  119. Reitan, 1963, The relationship of serum cholesterol changes to psychological abilities, J. Gerontol., 18, 350, 10.1093/geronj/18.4.350 · doi:10.1093/geronj/18.4.350
  120. Reynolds, 2009, A survey of ABCA1 sequence variation confirms association with dementia, Hum. Mutat., 30, 1, 10.1002/humu.21076 · DOI · Paper page
  121. Reynolds, 2006, Longitudinal memory performance during normal aging: twin association models of APOE and other Alzheimer candidate genes, Behav. Genet., 36, 185, 10.1007/s10519-005-9027-6 · DOI
  122. Robinson, 2002, Aβ as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease, Neurobiol. Aging, 23, 1051, 10.1016/S0197-4580(01)00342-6 · DOI
  123. Roher, 1999, Amyloid and lipids in the pathology of Alzheimer disease, Amyloid: J. Protein Folding Dis., 6, 136, 10.3109/13506129909007315 · DOI · Paper page
  124. Romero, 2009, Carotid artery atherosclerosis. MRI indices of brain ischemia, aging, and cognitive impairment: the Framingham study, Stroke, 40, 1590, 10.1161/STROKEAHA.108.535245 · DOI · Paper page
  125. Ronald, 2009, Clinical field-strength MRI of amyloid plaques induced by low-level cholesterol feeding in rabbits, Brain, 132, 1346, 10.1093/brain/awp031 · DOI
  126. Sagare, 2007, Clearance of amyloid-β by circulating lipoprotein receptors, Nat. Med., 13, 1029, 10.1038/nm1635 · DOI · Paper page
  127. Salo, 2002, Does apolipoprotein E influence learning and memory in the nondemented oldest old?, Int. Psychogeriatr., 13, 451, 10.1017/S1041610201007864 · DOI · Paper page
  128. Savory, 2002, Is amyloid β-peptide neurotoxic or neuroprotective and what is its role in the binding of metal ions?, Neurobiol. Aging, 23, 1089, 10.1016/S0197-4580(02)00037-4 · DOI
  129. Schachter, 1997, Calcium antagonists and atherosclerosis, Int. J. Cardiol., 62, S9, 10.1016/S0167-5273(97)00236-2 · doi:10.1016/s0167-5273(97)00236-2
  130. Schafers, 2008, Effects of cytokines on neuronal excitability, Neurosci. Lett., 437, 188, 10.1016/j.neulet.2008.03.052 · DOI · Paper page
  131. Schmajuk, 1990, Eyeblink conditioning in rats, Physiol. Behav., 48, 755, 10.1016/0031-9384(90)90221-O · doi:10.1016/0031-9384(90)90221-o
  132. Schreurs, 2007, Classical conditioning of the rabbit's nictitating membrane response is a function of the duration of dietary cholesterol, Nutr. Neurosci., 10, 159, 10.1080/10284150701565540 · DOI
  133. Schreurs, 2007, High dietary cholesterol facilitates classical conditioning of the rabbit's nictitating membrane response, Nutr. Neurosci., 10, 31, 10.1080/10284150701232034 · DOI
  134. Schreurs, 2007, Cholesterol enhances classical conditioning of the rabbit heart rate response, Behav. Brain Res., 181, 52, 10.1016/j.bbr.2007.03.024 · DOI
  135. Schreurs, 2003, Cholesterol modifies classical conditioning of the rabbit (Oryctolagus cuniculus) nictitating membrane response, Behav. Neurosci., 117, 1220, 10.1037/0735-7044.117.6.1220 · DOI
  136. Servatius, 2003, Facilitated acquisition of the classically conditioned eyeblink response in male rats after systemic IL-1β, Integr. Physiol. Behav. Sci., 38, 169, 10.1007/BF02688851 · DOI
  137. Sharma, 2008, Hypercholesterolemia-induced Aβ accumulation in rabbit brain is associated with alteration in IGF-1 signaling, Neurobiol. Dis., 32, 426, 10.1016/j.nbd.2008.08.002 · DOI · Paper page
  138. Simons, 2001, Cholesterol and Alzheimer's disease: Is there a link?, Neurology, 57, 1089, 10.1212/WNL.57.6.1089 · DOI · Paper page
  139. Singh-Manoux, 2008, Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study, Arteriosclerosis, Thrombosis Vasc. Biol., 28, 1556, 10.1161/ATVBAHA.108.163998 · DOI · Paper page
  140. Sjogren, 2006, Cholesterol and Alzheimer's disease—Is there a relation?, Mech. Ageing Dev., 127, 138, 10.1016/j.mad.2005.09.020 · DOI
  141. Skelton, 1988, Bilateral cerebellar lesions disrupt conditioned eyelid responses in unrestrained rats, Behav. Neurosci., 102, 586, 10.1037/0735-7044.102.4.586 · doi:10.1037/0735-7044.102.4.586
  142. Small, 2000, Is ApoE-ɛ4 a risk factor for cognitive impairment in normal aging?, Neurology, 54, 2082, 10.1212/WNL.54.11.2082 · DOI · Paper page
  143. Solomon, 2007, Serum cholesterol changes after midlife and late-life cognition, Neurology, 68, 751, 10.1212/01.wnl.0000256368.57375.b7 · DOI · Paper page
  144. Solomon, 2009, Cholesterol-modifying strategies for Alzheimer's disease, Expert Rev. Neurotherap., 9, 695, 10.1586/ern.09.25 · DOI · Paper page
  145. Sparks, 1997, Coronary artery disease, hypertension, ApoE and cholesterol: a link to Alzheimer's disease, Ann. N. Y. Acad. Sci., 826, 128, 10.1111/j.1749-6632.1997.tb48466.x · DOI · Paper page
  146. Sparks, 2004, Cholesterol, copper, and accumulation of thioflavine s-reactive Alzheimer's-like amyloid β in rabbit brain, J. Mol. Neurosci., 24, 97, 10.1385/JMN:24:1:097 · DOI
  147. Sparks, 2007, Cholesterol metabolism and brain amyloidosis: evidence for a role of copper in the clearance of Aβ through the liver, Curr. Alzheimer Res., 4, 165, 10.2174/156720507780362119 · DOI
  148. Sparks, 2002, HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advised to use one that crosses the blood-brain barrier, J. Nutr. Health Aging, 6, 324
  149. Sparks, 2006, Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial, Acta Neurol. Scand., 114, s3, 10.1111/j.1600-0404.2006.00690.x · DOI · Paper page
  150. Sparks, 2008, Reduced risk of incident AD with elective statin use in a clinical trial cohort, Curr. Alzheimer Res., 5, 416, 10.2174/156720508785132316 · DOI · Paper page
  151. Sparks, 2000, Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation. Preliminary observations, Ann. N. Y. Acad. Sci., 903, 335, 10.1111/j.1749-6632.2000.tb06384.x · DOI · Paper page
  152. Sparks, 2002, Water quality has a pronounced effect on cholesterol-induced accumulation of Alzheimer amyloid (aβ) in rabbit brain, J. Alzheimer's Dis., 4, 523, 10.3233/JAD-2002-4609 · DOI
  153. Sparks, 2007, Influence of water quality on cholesterol induced systemic pathology, J. Nutr. Health Aging, 11, 189
  154. Sparks, 1994, Induction of Alzheimer-like β-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol, Exp. Neurol., 126, 88, 10.1006/exnr.1994.1044 · DOI · Paper page
  155. Sparks, 2003, Trace amounts of copper in water induce β-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease, Proc. Natl. Acad. Sci. U.S.A., 100, 11065, 10.1073/pnas.1832769100 · DOI · Paper page
  156. Stewart, 2001, Apolipoprotein E genotype, vascular risk and early cognitive impairment in an African Caribbean population, Dement. Geriatr. Cogn. Disord., 12, 251, 10.1159/000051267 · DOI
  157. Teunissen, 2003, Serum cholesterol, precursors and metabolites and cognitive performance in an aging population, Neurobiol. Aging, 24, 147, 10.1016/S0197-4580(02)00061-1 · DOI
  158. Thelen, 2006, High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels, J. Clin. Pharmacol., 46, 812, 10.1177/0091270006289851 · DOI · Paper page
  159. Thirumangalakudi, 2008, High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with the loss of working memory in mice, J. Neurochem., 106, 475, 10.1111/j.1471-4159.2008.05415.x · DOI · Paper page
  160. Upchurch, 1988, DBA/2Ibg mice are incapable of cholinergically-based learning in the Morris water maze, Pharmacol. Biochem. Behav., 29, 325, 10.1016/0091-3057(88)90164-5 · DOI
  161. van den Kommer, 2009, Total cholesterol and oxysterols: early markers for cognitive decline in elderly?, Neurobiol. Aging, 30, 534, 10.1016/j.neurobiolaging.2007.08.005 · DOI
  162. van der Staay, 2001, Behavioral phenotyping of mouse mutants, Behav. Brain Res., 125, 3, 10.1016/S0166-4328(01)00278-9 · DOI
  163. van Exel, 2002, Association between high-density lipoprotein and cognitive impairment in the oldest old, Ann. Neurol., 51, 716, 10.1002/ana.10220 · DOI · Paper page
  164. Veinbergs, 2002, Neurotoxic effects of apolipoprotein E4 are mediated via dysregulation of calcium homeostasis, J. Neurosci. Res., 67, 379, 10.1002/jnr.10138 · DOI · Paper page
  165. Veinbergs, 2000, Vitamin E supplementation prevents spatial learning deficits and dendritic alterations in aged apolipoprotein E-deficient mice, Eur. J. Neurosci., 12, 4541
  166. Viviani, 2007, Cytokines and neuronal ion channels in health and disease, Int. Rev. Neurobiol., 82, 247, 10.1016/S0074-7742(07)82013-7 · DOI · Paper page
  167. Voikar, 2002, Cognitive deficit and development of motor impairment in a mouse model of Niemann-Pick type C disease, Behav. Brain Res., 132, 1, 10.1016/S0166-4328(01)00380-1 · DOI
  168. Wahrle, 2002, Cholesterol-dependent γ-secretase activity in buoyant cholesterol-rich membrane microdomains, Neurobiol. Dis., 9, 11, 10.1006/nbdi.2001.0470 · DOI · Paper page
  169. Wegiel, 2007, Intraneuronal Aβ immunoreactivity is not a predictor of brain amyloidosis-β or neurofibrillary degeneration, Acta Neuropathol. (Berl.), 113, 389, 10.1007/s00401-006-0191-4 · DOI · Paper page
  170. West, 2008, Better memory functioning associated with higher total and low-density lipoprotein cholesterol levels in very elderly subjects without the apolipoprotein e4 allele, Am. J. Geriatr. Psychiatry, 16, 781, 10.1097/JGP.0b013e3181812790 · DOI · Paper page
  171. Wilson, 2002, The apolipoprotein E ɛ4 allele and decline in different cognitive systems during a 6-year period, Arch. Neurol., 59, 1154, 10.1001/archneur.59.7.1154 · DOI · Paper page
  172. Wollmer, 2007, Association study of cholesterol-related genes in Alzheimer's disease, Neurogenetics, 8, 179, 10.1007/s10048-007-0087-z · DOI
  173. Wolozin, 2000, Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors, Arch. Neurol., 57, 1439, 10.1001/archneur.57.10.1439 · DOI · Paper page
  174. Woodruff-Pak, 2007, A rabbit model of Alzheimer's disease: valid at neuropathological, cognitive, and therapeutic levels, J. Alzheimer's Dis., 11, 371, 10.3233/JAD-2007-11313 · DOI
  175. Woodruff-Pak, 1997, Nimodipine ameliorates impaired eyeblink classical conditioning in order rabbits in the long-delay paradigm, Neurobiol. Aging, 18, 641, 10.1016/S0197-4580(97)00159-0 · DOI
  176. Wu, 2003, Brain region-dependent increases in β-amyloid and apolipoprotein E levels in hypercholesterolemic rabbits, J. Neural. Transm., 110, 641, 10.1007/s00702-002-0809-1 · DOI
  177. Xu, 1998, Relationship between abnormal cholesterol synthesis and retarded learning in rats, Metabolism, 47, 878, 10.1016/S0026-0495(98)90130-5 · DOI
  178. Xue, 2007, Microglial activation in the hippocampus of hypercholesterolemic rabbits occurs independent of increased amyloid production, J. Neuroinflamm., 4, 20, 10.1186/1742-2094-4-20 · DOI · Paper page
  179. Yaffe, 2002, Serum lipoprotein levels, statin use, and cognitive function in older women, Arch. Neurol., 59, 378, 10.1001/archneur.59.3.378 · DOI · Paper page
  180. Yanagisawa, 2002, Cholesterol and pathological processes in Alzheimer's disease, J. Neurosci. Res., 70, 361, 10.1002/jnr.10348 · DOI · Paper page
  181. Yao, 2002, Function of β-amyloid in cholesterol transport: a lead to neurotoxicity, FASEB J., 16, 1677, 10.1096/fj.02-0285fje · DOI · Paper page
  182. Yehuda, 1993, Modulation of learning, pain thresholds, and thermoregulation in the rat by preparations of free purified α-linolenic and linoleic acids: determination of the optimal ω3-to-ω6 ratio, Proc. Natl. Acad. Sci. U.S.A., 90, 10345, 10.1073/pnas.90.21.10345 · DOI · Paper page
  183. Yehuda, 1998, Modulation of learning and neuronal membrane composition in the rat by essential fatty acid preparation: time-course analysis, Neurochem. Res., 23, 627, 10.1023/A:1022430620205 · DOI
  184. Zandi, 2005, Do statins reduce risk of incident dementia and Alzheimer's disease?, Arch. Gen. Psychiatry, 62, 217, 10.1001/archpsyc.62.2.217 · DOI · Paper page
  185. Zatta, 2002, Astrocytosis, microgliosis, metallothionein-I-II and amyloid expression in high cholesterol-fed rabbits, J. Alzheimer's Dis., 4, 1, 10.3233/JAD-2002-4101 · DOI · Paper page
  186. Zhao, 2009, Polar metabolite of cholesterol induces rat cognitive dysfunctions, Neuroscience, 164, 398, 10.1016/j.neuroscience.2009.08.027 · DOI
  187. Zhou, 2008, Genetic association between low-density lipoprotein receptor-related protein gene polymorphisms and Alzheimer's disease in Chinese Han population, Neurosci. Lett., 444, 109, 10.1016/j.neulet.2008.07.093 · DOI

Cited by

See all 105

Metadata

Authors
Schreurs, B. G.
Venue
Neuroscience & Biobehavioral Reviews
Publisher
Elsevier BV
Published
2010-07
Volume
34
Issue
8
Pages
1366-1379
ISSN
0149-7634 (ISSN-L)
OpenAlex
W2055488264
Cited by
105
References
47
FWCI
8.07
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effects of cholesterol on learning and memory. https://app.cochat.ai/papers/10.1016/j.neubiorev.2010.04.010
The paper
Schreurs, B. G. (2010). The effects of cholesterol on learning and memory. Neuroscience & Biobehavioral Reviews. https://doi.org/10.1016/j.neubiorev.2010.04.010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.